Who Deserves Ozempic?
There isn’t enough Ozempic for everyone who wants it. People with health conditions like type 2 dia...
There isn’t enough Ozempic for everyone who wants it. People with health conditions like type 2 dia...
In the United States, nearly 41 percent of the population is obese. In 2023, the American Academy of Pediatrics ap...
A patient coded at my hospital without having clear guidelines about what he wanted for treatment plan. It left the hosp...
Abstract Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Auth...
Publish date:Brian M. Cummings, MD and John J. Paris, SJ, PhD In The New York Times, almost overlooked amidst multiple arti...
Abstract Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Auth...
Publish date:Abstract This issue features a set of articles addressing allocation issues for drugs for COVID-19 that have not been ap...
Publish date:by Berklee Robins, MD, MA & Ashley Sweet, MD, MBE Vaccines are approved when it is clear that the benefits to the in...
by Dorit Reiss, PhD LLB, Art Caplan, PhD, and Working Group on Vaccine Ethics and Policy The question whether the F...
The Working Group on Compassionate Use and Preapproval Access (CUPA), a project of the NYU Grossman School of Medicine D...
by Amy C. Reese, Pharm.D. My pharmacy received a prescription for prednisolone solution written for a 5-year-old patient...
by Kiarash Aramesh M.D., Ph.D. The COVID-19 pandemic has been accompanied by a surge of pseudoscientific claims, sometim...